Patients with hereditary cancer syndromes may be at increased risk for the development of tumor-to-tumor metastases. To gain insight into the biological nature of these lesions in the central nervous system (CNS), to determine their prevalence in a familial neoplasia syndrome, and to better define their management, the authors retrospectively examined a series of cases in which metastatic lesions developed within hemangioblastomas in patients with von Hippel–Lindau (VHL) disease.
The study included all cases of VHL disease in which patients underwent resection of a CNS hemangioblastoma that contained a metastasis or were found at autopsy to have a metastasis to a hemangioblastoma between January 2002 and December 2005 at the National Institute of Neurological Disorders and Stroke (NINDS). Clinical, histopathological, imaging, and surgical and/or autopsy findings were analyzed.
Metastasis to a CNS hemangioblastoma was found in six resected tumors (8% of all hemangioblastomas resected from patients with VHL disease at the NINDS during the study period) from six patients (five women, one man; mean age at surgery 42.5 years). The primary site of metastatic disease was the kidney in five patients (renal cell carcinoma) and the pancreas in one (a pancreatic neuroendocrine tumor). Only one patient had systemic metastases at the time of resection of the hemangioblastoma containing the metastasis. Neurologically, all patients had remained at baseline or were improved at last clinical follow-up examination (mean follow-up duration 16.5 months, range 3–40 months). In all cases, postoperative imaging revealed that the hemangioblastoma resection was complete, and there was no evidence of recurrence in any of the patients at the last follow up. Two patients (including one who was also in the surgical group) were found at autopsy to have CNS metastases exclusively to spinal hemangioblastomas.
Hemangioblastomas are an early and preferred site for metastasis in VHL disease. Emerging histopathological techniques may lead to recognition of an increasing number of cases of tumor-to-hemangioblastoma metastasis. Management of cases involving tumor-to-hemangioblastoma metastases in VHL disease should be based on the histological characteristics of the primary tumor, extent of the primary disease, and completeness of the resection.
Abou-Hamden A, , Koszyca B, , Carney PG, , Sandhu N, & Blumbergs PC: Metastasis of renal cell carcinoma to haemangioblastoma of the spinal cord in von Hippel-Lindau disease: case report and review of the literature. Pathology 35:224–227, 2003
Altinoz MA, , Santaguida C, , Guiot MC, & Del Maestro RF: Spinal hemangioblastoma containing metastatic renal cell carcinoma in von Hippel–Lindau disease. Case report and review of the literature. J Neurosurg Spine 3:495–500, 2005
Andrew SM, & Gradwell E: Immunoperoxidase labelled antibody staining in differential diagnosis of central nervous system haemangioblastomas and central nervous system metastases of renal carcinomas. J Clin Pathol 39:917–919, 1986
Avery AK, , Beckstead J, , Renshaw AA, & Corless CL: Use of antibodies to RCC and CD10 in the differential diagnosis of renal neoplasms. Am J Surg Pathol 24:203–210, 2000
Bret P, , Streichenberger N, & Guyotat J: Metastasis of renal carcinoma to a cerebellar hemangioblastoma in a patient with von Hippel Lindau disease: a case report. Br J Neurosurg 13:413–416, 1999
Caroli E, , Salvati M, , Giangaspero F, , Ferrante L, & Santoro A: Intrameningioma metastasis as first clinical manifestation of occult primary breast carcinoma. Neurosurg Rev 29:49–54, 2005
Chambers PW, , Davis RL, , Blanding JD, & Buck FS: Metastases to primary intracranial meningiomas and neurilemomas. Arch Pathol Lab Med 104:350–354, 1980
Crockard HA, , Barnard RO, & Isaacson PG: Metastasis of carcinoma to hemangioblastoma cerebelli: case report. Neurosurgery 23:382–384, 1988
Delattre JY, , Krol G, , Thaler HT, & Posner JB: Distribution of brain metastases. Arch Neurol 45:741–744, 1988
Duffey BG, , Choyke PL, , Glenn G, , Grubb RL, , Venzon D, & Linehan WM, et al.: The relationship between renal tumor size and metastases in patients with von Hippel-Lindau disease. J Urol 172:63–65, 2004
Farnsworth J: Regressing melanoma metastasizing to an oligodendroglioma. Pathology 4:253–257, 1972
Fried BM: Metastatic inoculation of a meningioma by cancer cells from a bronchogenic carcinoma. Am J Pathol 6:47–52, 1930
Hamazaki S, , Nakashima H, , Matsumoto K, , Taguchi K, & Okada S: Metastasis of renal cell carcinoma to central nervous system hemangioblastoma in two patients with von Hippel-Lindau disease. Pathol Int 51:948–953, 2001
Hammel PR, , Vilgrain V, , Terris B, , Penfornis A, , Sauvanet A, & Correas JM, et al.: Pancreatic involvement in von Hippel-Lindau disease. Gastroenterology 119:1087–1095, 2000
Hough DM, , Stephens DH, , Johnson CD, & Binkovitz LA: Pancreatic lesions in von Hippel-Lindau disease: prevalence, clinical significance, and CT findings. AJR Am J Roentgenol 162:1091–1094, 1994
Hufnagel TJ, , Kim JH, , True LD, & Manuelidis EE: Immunohisto-chemistry of capillary hemangioblastoma. Immunoperoxidase-labeled antibody staining resolves the differential diagnosis with metastatic renal cell carcinoma, but does not explain the histogenesis of the capillary hemangioblastoma. Am J Surg Pathol 13:207–216, 1989
Hwang TL, , Close TP, , Grego JM, , Brannon WL, & Gonzales F: Predilection of brain metastasis in gray and white matter junction and vascular border zones. Cancer 77:1551–1555, 1996
Jamjoom A, , Kane N, & Nicoll J: Metastasis of a renal carcinoma to a cerebellar haemangioblastoma in a case of von Hippel-Lindau disease. Neurosurg Rev 15:231–234, 1992
Johnson JD, & Young B: Demographics of brain metastasis. Neurosurg Clin N Am 7:337–344, 1996
Jung SM, & Kuo TT: Immunoreactivity of CD10 and inhibin alpha in differentiating hemangioblastoma of central nervous system from metastatic clear cell renal cell carcinoma. Mod Pathol 18:788–794, 2005
LeBlanc RA: Metastasis of bronchogenic carcinoma to acoustic neurinoma. Case report. J Neurosurg 41:614–617, 1974
Libutti SK, , Choyke PL, , Bartlett DL, , Vargas H, , Walther M, & Lubensky I, et al.: Pancreatic neuroendocrine tumors associated with von Hippel Lindau disease: diagnostic and management recommendations. Surgery 124:1153–1159, 1998
Lonser RR, , Glenn GM, , Walther M, , Chew EY, , Libutti SK, & Linehan WM, et al.: von Hippel-Lindau disease. Lancet 361:2059–2067, 2003
Lonser RR, , Vortmeyer AO, , Butman JA, , Glasker S, , Finn MA, & Ammerman JM, et al.: Edema is a precursor to central nervous system peritumoral cyst formation. Ann Neurol 58:392–399, 2005
Lonser RR, , Weil RJ, , Wanebo JE, , DeVroom HL, & Oldfield EH: Surgical management of spinal cord hemangioblastomas in patients with von Hippel-Lindau disease. J Neurosurg 98:106–116, 2003
Lundin P, & Pedersen F: Volume of pituitary macroadenomas: assessment by MRI. J Comput Assist Tomogr 16:519–528, 1992
Mork SJ, & Rubinstein LJ: Metastatic carcinoma to glioma: a report of three cases with a critical review of the literature. J Neurol Neurosurg Psychiatry 51:256–259, 1988
Mottolese C, , Stan H, , Giordano F, , Frappaz D, , Alexei D, & Streichenberger N: Metastasis of clear-cell renal carcinoma to cerebellar hemangioblastoma in von Hippel Lindau disease: rare or not investigated?. Acta Neurochir (Wien) 143:1059–1063, 2001
Nielsen SL, & Posner JB: Brain metastasis localized to an area of infarction. J Neurooncol 1:191–195, 1983
Ohh M, , Yauch RL, , Lonergan KM, , Whaley JM, , Stemmer-Rachamimov AO, & Louis DN, et al.: The von Hippel-Lindau tumor suppressor protein is required for proper assembly of an extracellular fibronectin matrix. Mol Cell 1:959–968, 1998
Pallud J, , Nataf F, , Roujeau T, & Roux FX: Intraventricular haemorrhage from a renal cell carcinoma pituitary metastasis. Acta Neurochir (Wien) 147:1003–1004, 2005
Pamphlett R: Carcinoma metastasis to meningioma. J Neurol Neurosurg Psychiatry 47:561–563, 1984
Pasqualini R, , Bourdoulous S, , Koivunen E, , Woods VL Jr, & Ruoslahti E: A polymeric form of fibronectin has antimetastatic effects against multiple tumor types. Nat Med 2:1197–1203, 1996
Posner JB, & Chernik NL: Intracranial metastases from systemic cancer. Adv Neurol 19:579–592, 1978
Posnikoff J, & Stratford J: Carcinoma metastasis to malignant glioma; case report. Arch Neurol 3:559–563, 1960
Richardson JF, & Katayama I: Neoplasm to neoplasm metastasis. An acidophil adenoma harbouring metastatic carcinoma: a case report. Arch Pathol 91:135–139, 1971
Strang RR: Metastasis of a breast carcinoma to an intracerebral oligodendroglioma. Zentralbl Neurochir 25:206–210, 1965
Vortmeyer AO, , Weil RJ, & Zhuang Z: Proteomic applications for differential diagnosis of histologically identical tumors. Neurology 61:1626–1627, 2003
Wallach JB, & Edberg S: Metastases of cancer to primary intracranial tumor. Arch Neurol 1:191–194, 1959
Wanebo JE, , Lonser RR, , Glenn GM, & Oldfield EH: The natural history of hemangioblastomas of the central nervous system in patients with von Hippel-Lindau disease. J Neurosurg 98:82–94, 2003
Wong TW, & Bennington JL: Metastasis of a mammary carcinoma to an acoustic neuroma. Report of a case. J Neurosurg 19:1088–1093, 1962
All Time | Past Year | Past 30 Days | |
---|---|---|---|
Abstract Views | 2038 | 367 | 34 |
Full Text Views | 326 | 49 | 4 |
PDF Downloads | 231 | 29 | 6 |
EPUB Downloads | 0 | 0 | 0 |